FDA Inspection 984038 — Neostrata Company Inc
The FDA completed an inspection of Neostrata Company Inc on Aug 25, 2016 in Summit, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 25, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Summit, NJ (United States)